Fundraising March 15, 2025 – April 1, 2025 About fundraising

Terms search

9
TheCYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer
Christina Justenhoven; Christiane B. Pierl; Susanne Haas; Hans-Peter Fischer; Christian Baisch; Ute Hamann; Volker Harth; Beate Pesch; Thomas Brüning; Caren Vollmert; Thomas Illig; Jürgen Dippon; Yon-
10
No evidence for glutathione S-transferasesGSTA2,GSTM2,GSTO1,GSTO2, andGSTZ1in breast cancer risk
Irena E. Andonova; Christina Justenhoven; Stefan Winter; Ute Hamann; Christian Baisch; Sylvia Rabstein; Anne Spickenheuer; Volker Harth; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Varban Ganev; Hiltr
11
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying theCYP2C19*17 variant
Christina Justenhoven; Ofure Obazee; Stefan Winter; Fergus J. Couch; Janet E. Olson; Per Hall; Ulf Hannelius; Jingmei Li; Keith Humphreys; Gianluca Severi; Graham Giles; Melissa Southey; Laura Bagliet
12
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk
Christina Justenhoven; Elke Schaeffeler; Stefan Winter; Christian Baisch; Ute Hamann; Volker Harth; Sylvia Rabstein; Anne Spickenheuer; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Matthias Schwab; Hil
13
Polymorphisms in theUBC9andPIAS3genes of the SUMO-conjugating system and breast cancer risk
Thomas Dünnebier; Justo Lorenzo Bermejo; Susanne Haas; Hans-Peter Fischer; Christiane B. Pierl; Christina Justenhoven; Hiltrud Brauch; Christian Baisch; Michael Gilbert; Volker Harth; Anne Spickenheue
14
Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors
Christina Justenhoven; Christiane B. Pierl; Susanne Haas; Hans-Peter Fischer; Ute Hamann; Christian Baisch; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Caren Vollmert; Thomas Illig; Beate Pesch;
15
Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: A population-based case–control study and meta-analyses
Jolanta Lissowska; Mia M. Gaudet; Louise A. Brinton; Stephen J. Chanock; Beata Peplonska; Robert Welch; Witold Zatonski; Neonila Szeszenia-Dabrowska; Sue Park; Mark Sherman; Montserrat Garcia-Closas
17
The earwax-associated SNP c.538G>A (G180R) inABCC11is not associated with breast cancer risk in Europeans
Thomas Lang; Christina Justenhoven; Stefan Winter; Christian Baisch; Ute Hamann; Volker Harth; Yon-Dschun Ko; Sylvia Rabstein; Anne Spickenheuer; Beate Pesch; Thomas Brüning; Matthias Schwab; Hiltrud
18
No association of polymorphisms in the cell polarity geneSCRIBwith breast cancer risk
Thomas Dünnebier; Klaus Schlaefer; Michael Gilbert; Christian Baisch; Christina Justenhoven; Hiltrud Brauch; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Beate Pesch; Thomas Brüning; Yon-Dschun K
21
CombinedUGT1A1andUGT1A6genotypes together with a stressful life event increase breast cancer risk
Christina Justenhoven; Stefan Winter; Thomas Dünnebier; Ute Hamann; Christian Baisch; Sylvia Rabstein; Anne Spickenheuer; Volker Harth; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Hiltrud Brauch
22
MALDI-TOF MS and TaqMan® assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET)
Malgorzata Jaremko; Christina Justenhoven; Benny K. Abraham; Werner Schroth; Peter Fritz; Sandra Brod; Caren Vollmert; Thomas Illig; Hiltrud Brauch
25
No evidence thatGATA3rs570613 SNP modifies breast cancer risk
Sharon E. Johnatty; Fergus J. Couch; Zachary Fredericksen; Robert Tarrell; Amanda B. Spurdle; Jonathan Beesley; Xiaoqing Chen; kConFab Investigators; AOCS Group; The Swedish BRCA1 and BRCA2 Study Coll
26
TheCASP8-652 6N del promoter polymorphism and breast cancer risk: a multicenter study
Bernd Frank; Sushila H. Rigas; Justo Lorenzo Bermejo; Miriam Wiestler; Kerstin Wagner; Kari Hemminki; Malcolm W. Reed; Christian Sutter; Barbara Wappenschmidt; Sabapathy P. Balasubramanian; Alfons Mei